These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35410136)

  • 1. Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5 years of age in the Dominican Republic.
    Benoit Vásquez GI; Morrobel AL; Benjumea-Bedoya D; Del Corral-Londoño H
    BMC Infect Dis; 2022 Apr; 22(1):359. PubMed ID: 35410136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
    Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
    Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.
    Belgaumkar V; Chandanwale A; Valvi C; Pardeshi G; Lokhande R; Kadam D; Joshi S; Gupte N; Jain D; Dhumal G; Deluca A; Golub J; Gupta A; Kinikar A; Bollinger RC
    Int J Tuberc Lung Dis; 2018 Oct; 22(10):1179-1187. PubMed ID: 30236186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.
    Ngugi SK; Muiruri P; Odero T; Gachuno O
    BMC Infect Dis; 2020 Apr; 20(1):294. PubMed ID: 32664847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.
    Zelner JL; Murray MB; Becerra MC; Galea J; Lecca L; Calderon R; Yataco R; Contreras C; Zhang Z; Grenfell BT; Cohen T
    Am J Respir Crit Care Med; 2014 Apr; 189(7):853-9. PubMed ID: 24592878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study.
    Okwara FN; Oyore JP; Were FN; Gwer S
    BMC Infect Dis; 2017 Sep; 17(1):623. PubMed ID: 28915796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
    Jacobson KB; Niccolai L; Mtungwa N; Moll AP; Shenoi SV
    AIDS Care; 2017 Jul; 29(7):936-942. PubMed ID: 28147705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Isoniazid Preventive Therapy among children living with tuberculosis patients in Delhi, India: An exploratory prospective study.
    Sharma N; Basu S; Khanna A; Sharma P; Chopra KK; Chandra S
    Indian J Tuberc; 2022 Jan; 69(1):100-103. PubMed ID: 35074140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point.
    Tadesse Y; Gebre N; Daba S; Gashu Z; Habte D; Hiruy N; Negash S; Melkieneh K; Jerene D; K Haile Y; Kassie Y; Melese M; G Suarez P
    PLoS One; 2016; 11(5):e0155525. PubMed ID: 27196627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
    Triasih R; Padmawati RS; Duke T; Robertson C; Sawyer SM; Graham SM
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1078-83. PubMed ID: 27393543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
    Briggs MA; Emerson C; Modi S; Taylor NK; Date A
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study.
    Birungi FM; Graham SM; Uwimana J; Musabimana A; van Wyk B
    PLoS One; 2019; 14(2):e0211934. PubMed ID: 30742660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste.
    Hall C; Sukijthamapan P; dos Santos R; Nourse C; Murphy D; Gibbons M; Francis JR
    Trop Med Int Health; 2015 Jun; 20(6):730-6. PubMed ID: 25682846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics.
    Zegarra-Chapoñan R; Bonadonna LV; Yuen CM; Martina-Chávez MB; Zeladita-Huaman J
    Infect Dis Poverty; 2021 May; 10(1):63. PubMed ID: 33962691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania.
    Nyarubamba RF; Silumbwe A; Jacobs C; Maritim P; Mdoe P; Zulu JM
    BMC Infect Dis; 2022 Nov; 22(1):884. PubMed ID: 36434517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health system barriers to implementation of TB preventive strategies in South African primary care facilities.
    Van Ginderdeuren E; Bassett J; Hanrahan C; Mutunga L; Van Rie A
    PLoS One; 2019; 14(2):e0212035. PubMed ID: 30763378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing the loop in child TB contact management: completion of TB preventive therapy outcomes in western Kenya.
    Amisi JA; Carter EJ; Masini E; Szkwarko D
    BMJ Open; 2021 Feb; 11(2):e040993. PubMed ID: 33622944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.